Loneliness, but Not Social Isolation, Tied to CVD Risk With Diabetes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, July 3, 2023 -- Loneliness is associated with a higher risk for cardiovascular disease (CVD) in patients with diabetes, according to a study published online June 29 in the European Heart Journal.
Xuan Wang, M.D., Ph.D., from the Tulane University School of Public Health and Tropical Medicine in New Orleans, and colleagues examined prospective associations between loneliness and social isolation with CVD risk in patients with diabetes. The analysis included data from 18,509 participants in the U.K. Biobank.
The researchers found that during a mean follow-up of 10.7 years, compared with participants with the lowest loneliness score (0), the risk for CVD was higher for participants with a loneliness scale score of 1 and 2 (hazard ratios, 1.11 and 1.26, respectively) in an adjusted analysis. There were no significant associations observed for social isolation. For predicting CVD, loneliness ranked higher in relative strength than lifestyle risk factors in patients with diabetes. There was a significant additive interaction noted between loneliness and the degree of risk factor control on the risk for CVD.
"Loneliness ranked higher as a predisposing factor for cardiovascular disease than several lifestyle habits. We also found that for patients with diabetes, the consequence of physical risk factors (i.e., poorly controlled blood sugar, high blood pressure, high cholesterol, smoking, and poor kidney function) was greater in those who were lonely compared to those who were not," a coauthor said in a statement. "The findings suggest that asking patients with diabetes about loneliness should become part of standard assessment, with referral of those affected to mental health services."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation
WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.